Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • AChR
    (1)
  • GNRH Receptor
    (1)
  • Potassium Channel
    (1)
  • ROR
    (1)
  • SARS-CoV
    (1)
  • TGF-beta/Smad
    (1)
  • Others
    (4)
TargetMol | Tags By ResearchField
  • Nervous System
    (3)
  • Cardiovascular System
    (2)
  • Cancer
    (1)
  • Infection
    (1)
Filter
Search Result
Results for "

T2510

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    6
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
Galunisertib
LY2157299
T2510700874-72-2
Galunisertib (LY2157299) is a TGF-β receptor type I (TGF-βRI) inhibitor (IC50=56 nM) that is selective. Galunisertib has antitumor activity and can be used in combination with PD-1 inhibitors.
  • $40
In Stock
Size
QTY
TargetMol | Citations Cited
Aprikalim
RP-52891, RP52891, RP 52891
T25102132562-26-6In house
Aprikalim (RP 52891) is an adenosine triphosphate potassium channel (KATP) opener that protects against nerve damage in a rabbit model of spinal cord ischemia.Aprikalim inhibits vasoconstriction and inhibits the elevation of [Ca2+]i during myocardial paralysis, and can be used to study cardiovascular disease.
  • $293 TargetMol
In Stock
Size
QTY
Aprofene
aprophen, Aprofenum
T251043563-01-7
Aprofene (Aprophen) is an antagonist of muscarinic and nicotinic acetylcholine receptors. It may be used in the therapy of peptic ulcers, endarteritis (inflammation of the inner shell of the artery), cholecystitis (inflammation of the gallbladder), and sp
  • $1,520
4-6 weeks
Size
QTY
APTAA-LHRH
Org-31276, Org31276, Org 31276, APTAALHRH
T2510583539-08-6
APTAA-LHRH is a gonadorelin antagonist.
  • $1,520
Inquiry
Size
QTY
Aranotin
Lilly 53185, L-53185, L53185, L 53185, Antibiotic A 21101-IL
T2510619885-51-9
Aranotin is a fungal toxin isolated from Arachniotus aureus with activity against RNA viruses such as poliovirus, coxsackie virus, and rhino- and parainfluenza viruses. Aranotin inhibits viral RNA synthesis by impeding the activity of RNA-dependent RNA polymerase.
  • $1,520
6-8 weeks
Size
QTY
ARN-6039
ARN6039, ARN 6039
T251091675206-11-7
ARN-6039, an orally available inverse agonist of RORγ, targets Autoimmune Neuroinflammatory Demyelinating Disease. Its efficacy was demonstrated in a RORγ-activated IL-17A Prom/LUCPorter assay in HEK 293 cells (360 nM) and in IL-17 release from CD4+T cell assays (220 nM).
  • $1,520
4-6 weeks
Size
QTY